logo
Plus   Neg
Share
Email

EDF Terminates Arenh Contracts With 3 Energy Suppliers

French electric utility EDF (EDFEF.PK) said it has notified three energy suppliers of the termination of their Arenh contracts.

The company has terminated the contracts linking it with the Alpiq, Gazel and Total Direct Energie power suppliers. The decision is as provided for in the contracts when an interruption occurs for a period of over two months.

The company noted that Covid-19 health crisis and the emergency measures introduced by public authorities on March 17 led to a decline in electricity consumption by non-residential clients, impacting all market players, including EDF.

Due to this, some suppliers decided to revoke their contractual commitments citing force majeure to reduce the volumes bought last November as part of the Arenh contract.

In May, Paris Commercial Court, in a ruling, considered that the conditions for force majeure regarding the Arenh contracts with Alpiq, Gazel and Total Direct Energie, were fulfilled since the introduction of emergency measures by the government. This leads to the termination of the Arenh contracts for these suppliers.

EDF said it firmly rejects the existence of force majeure conditions relative to the Arenh contracts and has filed an appeal with the Paris appeals court.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT